ClinicalTrials.govpublic full text
Vitamin D and SGLT-2 Inhibitor in CPAP-naive Obstructive Sleep Apnea
obstructive sleep apnea, hypertension, vitamin d, sodium glucose transporter-2 inhibitor, dapagliflozin, endothelial function, metabolic dysfunction associated steatotic liver disease, masld, heart rate variability, cardiac autonomic function, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 1046229
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.